Universal Health International Group Holding Limited logo

Universal Health International Group Holding Limited

2211.HK

HKSEHealthcareMedical - Pharmaceuticals

Latest quote

HK$0.785

+HK$0.025 · +3.29%

Aug 24, 1:56 PM HKTData delayed

2211.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Operating as an investment holding company, Universal Health International Group Holding Limited specializes in the wholesale, retail, and distribution of a comprehensive range of pharmaceutical and healthcare products across China's northeastern region. Its extensive offerings span both Western and traditional Chinese medicines, including patent medicines, chemical preparations, antibiotics, biochemical and biological drugs, traditional Chinese medicine decoction pieces, protein assimilation preparations, peptide hormones, and blood products. The company also supplies medical equipment, disinfection products, nutritional and prepackaged foods, health care items, cosmetics, daily necessities, and specific consumer goods such as family planning supplies (e.g., contraceptives) and infant formula milk powder. Furthermore, Universal Health International Group Holding Limited provides storage services to its varied clientele, which includes pharmaceutical retailers, hospitals, clinics, and distributors. Founded in 1998, the enterprise was formerly known as Jintian Pharmaceutical Group Limited until its rebranding in July 2015, and its corporate headquarters are located in Shenyang, People's Republic of China.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
Headquarters
CN
CEO
Chuanfu Chu
Listed since
Dec 12, 2013
Employees
665

Market position

Volume
7.38M
3.69× average
Average volume
2M
Average daily volume
Market cap
69.7M HKD
Beta
-0.52
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
97.1M CNY
P/E (TTM)
-2.38×
P/B (TTM)
0.19×
P/S (TTM)
0.11×
EV / EBITDA
-8.2×
Earnings yield
-30.41%
Free cash flow yield
-70.07%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
16.84%
Operating margin
-3.91%
Net margin
-4.48%
Return on equity
-8.19%
Return on assets
-5.81%
Return on invested capital
-7.46%

Financial health

Debt / equity
0.19×
Current ratio
1.31×

Earnings

Latest EPS result
-0.01

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.14-0.37-0.89-1.41Q2 '21Q4 '21Q2 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25
Q2 2021, reported Jun 30, 2021: actual -1.3, estimate —, surprise —, Comparison unavailable. Q4 2021, reported Dec 31, 2021: actual -0.38, estimate —, surprise —, Comparison unavailable. Q2 2022, reported Jun 30, 2022: actual -0.153, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Feb 24, 2023: actual -0.091, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Sep 28, 2023: actual -0.108, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Feb 28, 2024: actual -0.035, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Sep 26, 2024: actual 0.034, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 25, 2025: actual -0.011, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates5.7B3.93B2.16B398.9MQ2 '21No estimateQ4 '21No estimateQ2 '22No estimateQ1 '23MissQ3 '23MissQ1 '24MissQ3 '24No estimateQ1 '25No estimate
Q2 2021, reported Jun 30, 2021: actual 717.67M HKD, estimate —, surprise —, Comparison unavailable. Q4 2021, reported Dec 31, 2021: actual 755.05M HKD, estimate —, surprise —, Comparison unavailable. Q2 2022, reported Jun 30, 2022: actual 768.98M HKD, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Feb 24, 2023: actual 907.69M HKD, estimate 5.31B HKD, surprise -82.90%, Miss. Q3 2023, reported Sep 28, 2023: actual 540.78M HKD, estimate 5.31B HKD, surprise -89.81%, Miss. Q1 2024, reported Feb 28, 2024: actual 654.5M HKD, estimate 5.31B HKD, surprise -87.67%, Miss. Q3 2024, reported Sep 26, 2024: actual 534.48M HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 25, 2025: actual 469.3M HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

Dividend

Ex-dividend Sep 17, 2015

HK$0.0002

Quarterly

Record Sep 18, 2015 · Payment Oct 5, 2015

Dividend

Ex-dividend Jun 18, 2015

HK$0.0003

Semi-Annual

Record Jun 19, 2015 · Payment Jul 7, 2015

Dividend

Ex-dividend Sep 18, 2014

HK$0.0003

Semi-Annual

Record Sep 19, 2014 · Payment Oct 6, 2014

2211.HK peers

Continue in GoAI

Research 2211.HK

research.disclaimer